Guo W, Wang H, Li C (2021) Signal pathways of melanoma and targeted therapy. Signal Transduct Target Ther 6(1):424–424. https://doi.org/10.1038/s41392-021-00827-6

Article  PubMed  PubMed Central  Google Scholar 

Motwani J, Eccles MR (2021) Genetic and genomic pathways of melanoma development, invasion and metastasis. Genes 12(10):1543. https://doi.org/10.3390/genes12101543

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li FZ, Dhillon AS, Anderson RL, McArthur G, Ferrao PT (2015) Phenotype switching in melanoma: implications for progression and therapy. Front Oncol 5:31. https://doi.org/10.3389/fonc.2015.00031

Article  PubMed  PubMed Central  Google Scholar 

Datta A et al (1882) Cytoskeletal dynamics in epithelial-mesenchymal transition: insights into therapeutic targets for cancer metastasis. Cancers 13(8):2021. https://doi.org/10.3390/cancers13081882

Article  CAS  Google Scholar 

Pedri D, Karras P, Landeloos E, Marine J-C, Rambow F (2022) Epithelial-to-mesenchymal-like transition events in melanoma. FEBS J 289(5):1352–1368. https://doi.org/10.1111/febs.16021

Article  CAS  PubMed  Google Scholar 

Helmbach H, Rossmann E, Kern MA, Schadendorf D (2001) Drug-resistance in human melanoma. Int J Cancer 93(5):617–622. https://doi.org/10.1002/ijc.1378

Article  CAS  PubMed  Google Scholar 

Li R-H et al (2015) Temozolomide for Treating Malignant Melanoma. J Coll Physicians Surg Pak JCPSP 25(9):680–688

PubMed  Google Scholar 

Quirt I, Verma S, Petrella T, Bak K, Charette M (2007) Temozolomide for the treatment of metastatic melanoma: a systematic review. Oncologist 12(9):1114–1123. https://doi.org/10.1634/theoncologist.12-9-1114

Article  CAS  PubMed  Google Scholar 

Li T et al (2018) Histone deacetylase 6 in cancer. J Hematol Oncol J Hematol Oncol 11(1):111. https://doi.org/10.1186/s13045-018-0654-9

Article  CAS  PubMed  Google Scholar 

Liang T, Fang H (2018) Structure, Functions and Selective Inhibitors of HDAC6. Curr Top Med Chem 18(28):2429–2447. https://doi.org/10.2174/1568026619666181129141822

Article  CAS  PubMed  Google Scholar 

Liu J et al (2016) Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells. J Transl Med 14:7. https://doi.org/10.1186/s12967-015-0753-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu Z, Rong Y, Li S, Qu S, Huang S (2020) Upregulated histone deacetylase 6 associates with malignant progression of melanoma and predicts the prognosis of patients. Cancer Manag Res 12:12993–13001. https://doi.org/10.2147/CMAR.S284199

Article  CAS  PubMed  PubMed Central  Google Scholar 

Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL (2003) Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci U S A 100(8):4389–4394. https://doi.org/10.1073/pnas.0430973100

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hubbert C et al (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417(6887):455–458. https://doi.org/10.1038/417455a

Article  CAS  PubMed  Google Scholar 

Zilberman Y, Ballestrem C, Carramusa L, Mazitschek R, Khochbin S, Bershadsky A (2009) Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6. J Cell Sci 122(Pt 19):3531–3541. https://doi.org/10.1242/jcs.046813

Article  CAS  PubMed  Google Scholar 

Hideshima T et al (2016) Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma. Proc Natl Acad Sci USA 113(46):13162–13167. https://doi.org/10.1073/pnas.1608067113

Article  CAS  PubMed  PubMed Central  Google Scholar 

Friedrich J, Seidel C, Ebner R, Kunz-Schughart LA (2009) Spheroid-based drug screen: considerations and practical approach. Nat Protoc 4(3):309–324. https://doi.org/10.1038/nprot.2008.226

Article  CAS  PubMed  Google Scholar 

Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27–55. https://doi.org/10.1016/0065-2571(84)90007-4

Article  CAS  PubMed  Google Scholar 

Franken NAP, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1(5):2315–2319. https://doi.org/10.1038/nprot.2006.339

Article  CAS  PubMed  Google Scholar 

Martinotti S, Ranzato E (2020) Scratch Wound Healing Assay. Methods Mol Biol Clifton NJ 2109:225–229. https://doi.org/10.1007/7651_2019_259

Article  CAS  Google Scholar 

Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9(7):671–675. https://doi.org/10.1038/nmeth.2089

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sant S, Johnston PA (2017) The production of 3D tumor spheroids for cancer drug discovery. Drug Discov Today Technol 23:27–36. https://doi.org/10.1016/j.ddtec.2017.03.002

Article  PubMed  PubMed Central  Google Scholar 

Wong RSY (2011) Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res CR 30(1):87. https://doi.org/10.1186/1756-9966-30-87

Article  CAS  PubMed  Google Scholar 

Boulares AH et al (1999) Role of Poly(ADP-ribose) Polymerase (PARP) Cleavage in Apoptosis: caspase 3-resistant parp mutant increases rates of apoptosis in transfected cells *. J Biol Chem 274(33):22932–22940. https://doi.org/10.1074/jbc.274.33.22932

Article  CAS  PubMed  Google Scholar 

Chaitanya GV, Steven AJ, Babu PP (2010) PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal CCS 8:31. https://doi.org/10.1186/1478-811X-8-31

Article  CAS  PubMed  Google Scholar 

Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3(5):362–374. https://doi.org/10.1038/nrc1075

Article  CAS  PubMed  Google Scholar 

Eggermont AMM et al (2021) Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. Lancet Oncol 22(5):643–654. https://doi.org/10.1016/S1470-2045(21)00065-6

Article  CAS  PubMed  Google Scholar 

Nelson WJ, Nusse R (2004) Convergence of Wnt, ß-Catenin, and Cadherin Pathways. Science 303(5663):1483–1487. https://doi.org/10.1126/science.1094291

Article  CAS  PubMed  PubMed Central  Google Scholar 

Na T-Y, Schecterson L, Mendonsa AM, Gumbiner BM (2020) The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci USA 117(11):5931–5937. https://doi.org/10.1073/pnas.1918167117